Antirheumatic drugs and the risk of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: A nationwide, population-based cohort study.
Chia-Chu MengDer-Yuan ChenYi-Hsing ChenWen-Nan HuangHsin-Hua ChenPublished in: International journal of rheumatic diseases (2023)
This study reveals that NSAID use and prednisolone equivalent dose >5 mg/day were associated with an increased risk of NAFLD in patients with RA, while the use of HCQ and prednisolone equivalent dose ≤5 mg/day decreased the risk of NAFLD.